DXCM

SELL

DexCom, Inc.

Healthcare · Rank #121 · Analyzed Apr 20, 2026

$63.98

Current Price

$29.50

Intrinsic Value

-35.8%

Upside/Downside

4.5/10

Score

4.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score4.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 35.8%

Fair Value Range

Low$5.69

Base (IV)$29.50

High$41.07

Entry Points

Conservative$5.69

Moderate$17.60

Aggressive$29.50

Quality & Moat Breakdown

Return on Equity34.5% → 1.0/1.0

Debt LevelD/E 51 → 0.5/1.0

Revenue QualityGrowth 16.6%, margin Δ-2.3% +recovery → 1.0/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins17.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.